Pharmaceutical Technology

JUNE 19, 2025

Actio Biosciences CEO and co-founder David Goldstein stated: “We have made tremendous progress across our pipeline – executing a precision medicine strategy that targets the root causes of disease through genetically informed drug development. Give your business an edge with our leading industry insights.

Communication 52

Communication Hospitals Drug Development Pharmaceutical Manufacturing 52

Pharmaceutical Technology

JUNE 19, 2025

Kisunla and Leqembi were touted as the most promising treatments to emerge from Alzheimer’s drug development in recent times. However, side effects from the drugs can be serious, and their high cost has been a barrier to reimbursement. Give your business an edge with our leading industry insights.

Communication 59

Communication Hospitals Drug Development Pharmaceutical Manufacturing 59

Pharmaceutical Technology

JUNE 19, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.

Communication 52

Communication Hospitals Pharmaceutical Manufacturing Packaging 52

Pharmaceutical Technology

JUNE 19, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.

Communication 52

Communication Hospitals Pharmaceutical Manufacturing Packaging 52

Pharmaceutical Technology

JUNE 19, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.

Communication 52

Communication Hospitals Pharmaceutical Manufacturing Packaging 52

Pharmaceutical Technology

JUNE 17, 2025

Syngene’s expertise in the field is covered in this white paper. “SIM0505 is a significantly differentiated CDH6 targeting ADC candidate independently developed by Simcere Zaiming. In January 2025, AbbVie and Simcere Zaiming entered an option-to-license agreement for the development of SIM0500.

Communication 52

Communication Hospitals Packaging Drug Development 52

Pharmaceutical Technology

DECEMBER 6, 2022

HPAPIs may now represent more than 30% of the drug development pipeline. Within that figure, GlobalData estimates that around 60% of pipeline HPAPIs are developed to target oncology. In the early stages of drug development, protecting operators from unknown risks is absolutely crucial.

Drug Development 52

Drug Development Dosage Pharmaceutical Manufacturing Communication 52

Pharmaceutical Technology

FEBRUARY 8, 2023

Despite the challenges that drug developers must overcome to produce gene therapies for rare diseases, Hart underscored the FDA’s intent to encourage more innovation in this space. “We Therefore, the good news is we have flexibilities that can be offered to see drug development for these diseases.”

Documentation 105

Documentation Drug Development Communication 105

Pharmaceutical Technology

DECEMBER 9, 2022

. <p>Early Access Programs (EAPs) are a pathway for pharmaceutical companies to provide innovative drugs to patients living with serious conditions. These treatments may still be in development or already have approval somewhere in the world. </p> </p> By Tanner Pharma Group.

Drug Pricing 98

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies Biosimilars 98

Pharmaceutical Technology

JUNE 12, 2025

Outsourcing is now a fundamental part of drug development and distribution. Outsourcing is now a fundamental part of drug development and distribution. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Health and Personal Care Stores 52

Health and Personal Care Stores Communication Drug Development Packaging 52

Pharmaceutical Technology

JANUARY 22, 2023

Nicklas Westerholm, the CEO and president of orphan drug developer Egetis Therapeutics, says disease awareness amongst paediatric neurologists and endocrinologists is low for MCT8 deficiency. The mutation leads to disordered thyroid hormone transport, which causes patients to experience intellectual and motor disabilities. on placebo.

Communication 126

Communication Dosage Drug Development 126

Pharmaceutical Technology

MARCH 6, 2023

Teijin Pharma is also eligible for up to $200m in potential development and commercial milestone payments along with further additional sales milestones as well as tiered annual net sales royalties. It stated that the candidate is believed to impact the pathogenesis of several kidney diseases and works in a genetically validated pathway.

Compounding 105

Compounding Communication Drug Development 105

Pharmaceutical Technology

FEBRUARY 24, 2023

Combining AbbVie’s expertise in eye disease drug development and commercialisation with Capsida’s fully integrated next-generation AAV engineering platform and manufacturing capabilities offers the potential to provide novel therapies enabling unprecedented benefit to patients with serious eye diseases.”

Communication 52

Communication Drug Development 52

Pharmaceutical Technology

JANUARY 12, 2023

Under the research partnership deal, the companies will develop new precision genetic medicines for a severe form of genetic dilated cardiomyopathy (DCM). Solid Biosciences stated that the partnership boosts its scientific capabilities along with commercial potential in cardiac therapy.

Communication 52

Communication Drug Development 52

Pharmaceutical Technology

DECEMBER 13, 2022

Prominent SaaS systems were a huge inspiration, McVeigh says, but the technical challenge presented by the drug development world came with different demands. At the same time, Suvoda has built a large API surface on top of the platform architecture that will simplify integrations with other eClinical systems.

Communication 104

Communication Drug Development 104

Pharmaceutical Technology

NOVEMBER 30, 2022

Over the past few years, there has been a boom in anti-obesity drug development, with major companies achieving substantial sales in the field. According to GlobalData, as of November 28, there were 316 generic and novel drugs marketed to treat obesity. Anti-obesity therapeutic landscape.

Insurance Coverage and Processing 105

Insurance Coverage and Processing Diabetes Labelling Communication 105

Pharmaceutical Technology

MAY 3, 2023

In a white paper titled “Access Denied: Why New Generics Are Not Reaching America’s Seniors,” the AAM analysis indicates that patients may wait up to three years for first generic competitors to costly brands. In 2017, FDA announced the Drug Competition Action Plan (DCAP) to allow consumers to get access to medicines.

Generic Medicine 98

Generic Medicine Drug Development Communication Diabetes 98

Pharmaceutical Technology

NOVEMBER 30, 2022

Over the past few years, there has been a boom in anti-obesity drug development, with major companies achieving substantial sales in the field. According to GlobalData, as of November 28, there were 316 generic and novel drugs marketed to treat obesity. Anti-obesity therapeutic landscape.

Insurance Coverage and Processing 98

Insurance Coverage and Processing Diabetes Labelling Communication 98

Pharmaceutical Technology

FEBRUARY 28, 2023

Biocytogen Pharmaceuticals president and CEO Dr Yuelei Shen said: “Chipscreen Biosciences and Chipscreen NewWay have extensive experience in clinical drug development and commercialisation. It also activated tumour-infiltrating DCs and T cells in vivo pharmacodynamic studies. Please check your email to download the Whitepaper.

Immunization 52

Immunization Immunity Communication Drug Development 52

Pharmaceutical Technology

MARCH 15, 2023

According to GlobalData’s Pharma Intelligence Center Deals Database, figure 1 shows the parent holding company SVB Financial Group and its subsidiaries were involved in more than $1.4bn in total venture financing raised from 2010 to 2022 for drug development. Free Report How is the Biopharmaceutical industry evolving?

Drug Development 59

Drug Development Communication 59

Pharmaceutical Technology

FEBRUARY 21, 2023

Versatility Finding a versatile R&D tablet press is key for flexible drug development. This is where compaction simulation really shines, believes Ingrid Coyle, MEDELPHARM’s director of corporate business development and communication. Every step has been thought of from a user experience perspective.”

Communication 52

Communication Drug Development Dosage 52

Pharmaceutical Technology

FEBRUARY 28, 2023

Orphan drug development is expanding Change is happening. 1983 was a pivotal year for the rare disease community, with the US Food and Drug Administration’s introduction of the Orphan Drug Act. With similar incentives offered by EU/EEA and UK law, orphan drug development has taken off.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Drug Development Communication 52

Pharmaceutical Technology

NOVEMBER 30, 2022

A vitally important assay used across various stages of drug development and manufacturing, container closure integrity testing (CCIT) involves evaluating packaging systems to determine their ability to protect the stability and sterility of pharmaceutical products. The evolution of CCIT.

Drug Development 52

Drug Development Packaging Communication 52

Pharmaceutical Technology

MARCH 9, 2023

Under the partnership, the Centre for Drug Development of Cancer Research UK will appoint the chief clinical and scientific investigators. The potential first-in-class antibody UCB6114 targets a glycoprotein secreted by the tumour stroma, gremlin-1. Please check your email to download the Whitepaper.

Communication 52

Communication Immunization Immunity Drug Development 52

Pharmaceutical Technology

NOVEMBER 28, 2022

To learn more about the development and partnership opportunities for businesses within Scotland’s health sector, download the document on this page. Precision Medicine: Streamlining Treatments and Drug Development. Free Whitepaper. Please check your email to download the Whitepaper.

Hospitals 52

Hospitals Packaging Medical Schools Documentation 52

Pharmaceutical Technology

JANUARY 26, 2023

RoslinCT also works in conjunction with the Scottish Universities Life Science Alliance, with Skills Development Scotland playing an important role in furthering capabilities. “We We are all aligned and in frequent communication with each other. It certainly drives things in the right direction,” adds Brownfield.

Communication 52

Communication Diabetes Drug Development 52

Pharmaceutical Technology

MARCH 23, 2023

Scientific research and a better understanding of the condition is driving new developments in medications. The condition’s symptoms are not homogeneous, and that makes drug development complicated,” Javier Szwarcberg, CEO of Spruce Biosciences, a rare disease company researching endocrine disorders, says.

Communication 52

Communication Drug Development 52

Pharmaceutical Technology

JUNE 20, 2025

In recent years, the pharmaceutical industry has exhibited a significant shift into digitalisation, with AI pushing for innovation across the entire drug development value chain, from accelerating drug discovery to optimising clinical trial design to ultimately improve patient outcomes.

52

52

Putting Patients First Blog

APRIL 14, 2023

10: External Data Submission Timing The NHC understands the tight timeline for the drug selection and price negotiation processes. As discussed in the NHC’s 2020 white paper on the topic,3 patient value is multi-faceted, and any attempts to distill important dimensions of patient value and benefit into a single number is fraught.

Drug Pricing 40

Drug Pricing Drug Development Documentation Communication 40

Pharmaceutical Technology

JUNE 20, 2025

We may still continue to send you service-related and other non-promotional communications. By Cytiva Thematic You have a right to withdraw your consent at any time, by clicking here. For more information relating to our privacy practices, we invite you to review our privacy policy. Sign up for our daily news round-up!

52

52

Pharmaceutical Technology

JUNE 20, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.

52

52

Pharmaceutical Technology

JUNE 20, 2025

Subscribe Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Give your business an edge with our leading industry insights.

52

52

Pharmaceutical Technology

JUNE 17, 2025

TEV-56278 demonstrates the strength of Teva’s innovative drug development capabilities and how strategic partnerships with companies such as Fosun Pharma play a pivotal role in advancing therapies on behalf of patients.” ” TEV-56278 has been specifically engineered to target PD-1 + T cells selectively.

Communication 52

Communication Hospitals Drug Development Packaging 52

Pharmaceutical Technology

FEBRUARY 1, 2023

Pharmaceutical companies are pushing to develop drugs and vaccines for RSV with these populations in mind. Since the FDA approved AstraZeneca’s monoclonal antibody therapy Synagis (palivizumab) 25 years ago, drug development successes for RSV have been few and far between.

Vaccines 64

Vaccines Drug Development Pharmaceutical Companies Pharmaceutical Companies 64

Pharmaceutical Technology

JUNE 18, 2025

He said the cuts concerned redundancies caused by certain departments having their own legislative, communication staff, and in other departments like HR and procurement – which constitute about 10% of the entire agency staff. Reports Use of Artificial Intelligence in Pharmaceutical Drug Development a.

Vaccines 52

Vaccines Communication Hospitals Drug Development 52

Pharmaceutical Technology

DECEMBER 8, 2022

Instead of starting with ‘what equipment do we have’, we’re really starting with our end goal by considering what is required by the drug developers,” explains Lenaerts. This is something that sets Datwyler’s approach apart from its competitors. Please check your email to download the Whitepaper.

Packaging 98

Packaging Vaccines Communication Drug Development 98

Pharmaceutical Technology

MARCH 24, 2023

In light of World TB day on March 24, the field hopes to overcome some major barriers to the drug development landscape. Unfortunately, lack of funding and resources remain an obstacle within the TB field for developing new vaccines. The BCG vaccine is a live-attenuated virus vaccine.

Vaccines 64

Vaccines Health and Personal Care Stores Immunization Immunity 64